These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Follow up study of thirty-six borderline cases of leprosy. Kundu S; Ghosh S Bull Calcutta Sch Trop Med; 1967 Jul; 15(3):103-4. PubMed ID: 5616299 [No Abstract] [Full Text] [Related]
23. [Results of modern therapy of leprosy]. Schuppli R Hautarzt; 1969 Mar; 20(3):116-8. PubMed ID: 5355958 [No Abstract] [Full Text] [Related]
24. Studies on sulfone resistance in leprosy. I. Detection of cases. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069 [No Abstract] [Full Text] [Related]
25. Treatment of sulphone resistant leprosy--a review of sixty one cases. Seshadri PS; Ravi NT Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123 [No Abstract] [Full Text] [Related]
26. [The main anti-leprosy drugs, their respective costs and refunding by Social Security]. Merklen FP Bull Acad Natl Med; 1968 Apr; 152(13):220-2. PubMed ID: 4913494 [No Abstract] [Full Text] [Related]
27. Gas chromatographic methods for analysis of sulfone drugs used in leprosy chemotherapy. Burchfield HP; Storrs EE; Wheeler RJ; Bhat VK; Green LL Anal Chem; 1973 May; 45(6):916-20. PubMed ID: 4762374 [No Abstract] [Full Text] [Related]
28. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy. Hastings RC; Trautman JR; Mansfield RE Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014 [No Abstract] [Full Text] [Related]
29. Use of "Novolep", a by-product of D.D.S., for the treatment of trophic ulcers (planter) in leprosy. Mahapatra SB Indian J Dermatol; 1975 Oct; 21(1):22-4. PubMed ID: 1234880 [No Abstract] [Full Text] [Related]
30. Further notes on the incidence of leprosy in Hong Kong children living with a lepromatous parent. Worth RM; Wong KO Int J Lepr Other Mycobact Dis; 1971; 39(3):745-9. PubMed ID: 5169925 [No Abstract] [Full Text] [Related]
31. Treatment of leprosy. Singh RP Indian J Dermatol; 1966 Jul; 11(4):151-2. PubMed ID: 5969952 [No Abstract] [Full Text] [Related]
32. [Drug-induced pathomorphosis of skin lesions in leprosy]. Vishnevetskiĭ FE Arkh Patol; 1971; 33(9):70-7. PubMed ID: 4336757 [No Abstract] [Full Text] [Related]
33. [Findings of the real value of sulphonotherapy in the programs of prevention of leprosy]. Lima Lde S Rev Bras Leprol; 1968-1969; 36(1):31-6. PubMed ID: 5748409 [No Abstract] [Full Text] [Related]
34. [Long-term observations on the topical administration of promin in ocular leprosy]. Bouzas A Arch Ophtalmol Rev Gen Ophtalmol; 1971; 31(8):629-36. PubMed ID: 4256932 [No Abstract] [Full Text] [Related]
35. [Early diagnosis, therapy, and research in the control of leprosy]. Contreras Duenas F Offentl Gesundheitswes; 1970 Dec; 32(12):667-71. PubMed ID: 4250373 [No Abstract] [Full Text] [Related]
36. Mechanism of action of sulfones. Bergel M Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):89-90. PubMed ID: 7195883 [No Abstract] [Full Text] [Related]
37. Follow-up study of nerve lesions in leprosy using the time intensity curve test. Magora A Int J Lepr Other Mycobact Dis; 1969; 37(2):164-72. PubMed ID: 4310800 [No Abstract] [Full Text] [Related]
38. Use of corticosteroids in persistent "lepra reaction". Kundu S; Ghosh S Bull Calcutta Sch Trop Med; 1966 Jan; 14(1):16-7. PubMed ID: 5961035 [No Abstract] [Full Text] [Related]
39. The etiology of erythema nodosum leprosum. Pettit JH; Waters MF Int J Lepr Other Mycobact Dis; 1967; 35(1):1-10. PubMed ID: 6067035 [No Abstract] [Full Text] [Related]
40. Controlled trials in the chemotherapy of leprosy. Long ER Int J Lepr Other Mycobact Dis; 1967; 35(3):388-91. PubMed ID: 4917110 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]